Skip to main content

Table 1 Baseline characteristics of study population (n = 44)

From: Continuity of care experienced by patients in a multi-institutional pancreatic care network: a pilot study

Patient Characteristic n (%)a
Age, yrs. (mean ± sd) 67.8 ± 9.1
Male sex 29 (65.9)
Patients with new diagnosis 30 (68.2)
Diagnosis
 Pancreatic carcinoma 12 (27.3)
 Metastatic pancreatic cancer 2 (4.5)
 pNET 3 (6.8)
 Pancreatic cystic neoplasms 9 (20.5)
 Bile duct cancer/ Ampullary carcinoma 4 (9.1)
 Chronic pancreatitis 9 (20.5)
 Other (e.g. metastases from elsewhere) 6 (13.6)
Number of MDTs per patient (mean ± sd) 2.0 ± 1.1
Repetition of CT-scan by tertiary center (PACON) 8 (42)
Repetition of MRI-scan by tertiary center (PACON) 12 (37.5)
Repetition of endoscopy by tertiary center (PACON) 4 (25)
Time (days) between diagnosis and treatment plan by PACONb (mean ± sd) 10.3 ± 15.8
Treatment advice
 Follow-up 14 (31.8)
 Surgery 10 (22.7)
 Neoadjuvant treatment with surgery 3 (6.8)
 Surgery with adjuvant chemotherapy 6 (13.6)
 Chemotherapy 1 (2.3)
 Other 8 (18.2)
 No treatment or no follow up indicated 2 (4.5)
Location of treatment
 Tertiary center (PACON) 25 (56.8)
 Referring hospital 4 (9.1)
 Combination of PACON and referring hospital 7 (15.9)
 Unknown/other 8 (18.2)
Outpatients visits to specialist tertiary center (mean ± sd) 3.15 ± 2.65
Phone consultation with specialist tertiary center (mean ± sd) 2.23 ± 1.50
  1. Abbreviations: pNET pancreatic neuroendocrine tumor, MDT Multidisciplinary team meeting, PACON Pancreatic Center East Netherlands (part of tertiary health center)
  2. aunless specified otherwise in patient characteristic. bFollow-up patients were excluded